30 results on '"Naber D"'
Search Results
2. Insight in schizophrenia–course and predictors during the acute treatment phase of patients suffering from a schizophrenia spectrum disorder
3. Remission as perceived by people with schizophrenia, family members and psychiatrists
4. Remitted but still impaired? Symptomatic versus functional remission in patients with schizophrenia
5. Response and remission of subjective well-being in patients suffering from schizophrenia spectrum disorders
6. Establishing remission and good clinical functioning in schizophrenia: Predictors of best outcome with long-term risperidone long-acting injectable treatment
7. Early improvement as a predictor of remission and response in schizophrenia: Results from a naturalistic study
8. Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence
9. Neuropsychological correlates of schizophrenic syndromes in patients treated with atypical neuroleptics
10. Neuroleptic-induced extrapyramidal symptoms are accompanied by cognitive dysfunction in schizophrenia
11. Aripiprazole Once-monthly is Superior to Paliperidone Palmitate in a Randomized, Head-to-head Clinical Study
12. 2521 – Clinical challenges in switching antipsychotics
13. P-1241 - Nurses' perceptions of assessment, causes and management of partial/non-adherence to medication: results of the EMEA adhes survey in schizophrenia
14. The EMEA ADHES survey in schizophrenia: psychiatrists’ perceptions of the extent of assessment and management of partial and non-adherence to medication
15. The EMEA ADHES survey in schizophrenia: psychiatrists’ perceptions of reasons for partial or non-adherence
16. Patient reported measures and functional remission
17. The EMEA ADHES survey in schizophrenia, an initiative to raise awareness of non-adherence to medication. demographics and methodology
18. P03-128 - A Flexible-Dose Study of Paliperidone ER in Non-Acute Patients with Schizophrenia Previously Unsuccessfully Treated with Oral Risperidone
19. PW01-193 - Safety And Efficacy Of Long-Term Asenapine Versus Olanzapine In Schizophrenia Or Schizoaffective Disorder Patients
20. S26-02 - Antipsychotic Treatment: Polypharmacy Versus Monotherapy
21. Subjective well-being Under Neuroleptic Treatment. Relevance for Compliance and Remission
22. Physical and Mental Health in Severe Opioid Dependent Patients Within a Randomised Controlled Maintenance Treatment Trial
23. Natriuretic peptides modulate the psychometric and endocrine effects of cholecystokinin tetrapeptide in man
24. S17-03 - Patient reported measures and functional remission
25. P03-277 - The EMEA ADHES survey in schizophrenia: psychiatrists’ perceptions of the extent of assessment and management of partial and non-adherence to medication
26. P03-276 - The EMEA ADHES survey in schizophrenia, an initiative to raise awareness of non-adherence to medication. demographics and methodology
27. P03-275 - The EMEA ADHES survey in schizophrenia: psychiatrists’ perceptions of reasons for partial or non-adherence
28. P01-64 Physical and mental health in severe opioid dependent patients within a randomised controlled maintenance treatment trial
29. S51-01 Subjective well-being under neuroleptic treatment. Relevance for compliance and remission
30. Schizophrenic patients' retrospective attitudes regarding involuntary psychopharmacological treatment and restaint
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.